Hyperbaric Oxygen Therapy Initiation Time in Acute Carbon Monoxide Poisoning
Effect of Hyperbaric Oxygen Therapy Initiation Time in Acute Carbon Monoxide Poisoning
1 other identifier
observational
706
1 country
1
Brief Summary
Hyperbaric oxygen therapy (HBO2) is recommended for symptomatic patients within 24 h of carbon monoxide (CO) poisoning. However, previous major studies found significantly better outcomes with HBO2 in patients treated within 6 h. Currently, there is no consensus on a CO poisoning-to-HBO2 interval that would not be beneficial. Therefore, the investigators aimed to evaluate the difference in therapeutic effect depending on the poisoning-to-HBO2 interval after CO exposure in patients with acute CO poisoning who received HBO2 within 24 h. The investigators compared the neurocognitive outcomes of patients according to HBO2 time intervals based on the outcomes of patients treated within 6 h (control group) with propensity score matching using the CO poisoning registry of our hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2020
CompletedFirst Submitted
Initial submission to the registry
November 30, 2020
CompletedFirst Posted
Study publicly available on registry
December 7, 2020
CompletedDecember 29, 2020
December 1, 2020
2 months
November 30, 2020
December 27, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Frequency of poor global deterioration scale (GDS) at 1 month after CO exposure in the overall matched cohort
Frequency of poor GDS (4-7 scores) outcome at 1 month after CO exposure between early group and late group \*GDS (the minimum and maximum: 1-7, higher scores mean a worse outcome) Poor GDS outcome means from 4 to 7 in GDS score.
At 1 month after CO exposure
Frequency of poor GDS at 6 months after CO exposure in the overall matched cohort
Frequency of poor GDS outcome at 6 months after CO exposure between early group and late group
At 6 months after CO exposure
Secondary Outcomes (12)
Frequency of poor GDS at 1 month after CO exposure between early group and case 1 group in the matched cohort
At 1 month after CO exposure
Frequency of poor GDS at 1 month after CO exposure between early group and case 2 group in the matched cohort
At 1 month after CO exposure
Frequency of poor GDS at 1 month after CO exposure between case 1 group and case 2 group in the matched cohort
At 1 month after CO exposure
Frequency of poor GDS at 6 months after CO exposure between early group and case 1 group in the matched cohort
At 6 months after CO exposure
Frequency of poor GDS at 6 months after CO exposure between early group and case 2 group in the matched cohort
At 6 months after CO exposure
- +7 more secondary outcomes
Study Arms (1)
Acute CO poisoning
A diagnosis of CO poisoning was made according to medical history and carboxyhemoglobin \>5% (\>10% in smokers).
Interventions
Patients with any symptoms and signs were treated with HBO2. During the first HBO2, initial compression was performed to 2.8 atmospheres absolute (ATA) for 45 min, followed by 2.0 ATA for 60 min. If an additional HBO2 was possible within 24 h, then 2.0 ATA was administered for 90 min. Moreover, if necessary, patients were treated with HBO2, even after 24 h, until all symptoms resolved.
Eligibility Criteria
CO poisoned patients
You may qualify if:
- CO poisoned patients
You may not qualify if:
- Not treated with HBO2
- \< 16 years old
- Non-acute CO poisoning
- Received HBO2 more than 24 h after poisoning
- A history of previous stroke or neurocognitive diseases
- Did not undergo follow-up until 6 months
- Received specific treatment other than HBO2, such as therapeutic hypothermia
- A history of previous CO exposure
- A serious illness that can affect the patient's prognosis such as advanced cancer
- A cardiac arrest before ED arrival
- No recorded data on important variables, such as time from CO exposure to the start of first HBO2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wonju Severance Christian Hospital
Wŏnju, Gangwon-do, 26426, South Korea
Related Publications (1)
Lee Y, Cha YS, Kim SH, Kim H. Effect of Hyperbaric Oxygen Therapy Initiation Time in Acute Carbon Monoxide Poisoning. Crit Care Med. 2021 Oct 1;49(10):e910-e919. doi: 10.1097/CCM.0000000000005112.
PMID: 34074856DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 30, 2020
First Posted
December 7, 2020
Study Start
September 1, 2020
Primary Completion
October 30, 2020
Study Completion
October 30, 2020
Last Updated
December 29, 2020
Record last verified: 2020-12